中国临床药理学杂志2024,Vol.40Issue(21) :3167-3170.DOI:10.13699/j.cnki.1001-6821.2024.21.020

中医药调控p38-MAPK信号通路在心力衰竭心肌纤维化中的研究现状

Research status on the regulation of the p38-MAPK signaling pathway in myocardial fibrosis of heart failure using traditional Chinese medicine

王一博 沙万敏 秦亚录 魏华 毛琪玥 王言
中国临床药理学杂志2024,Vol.40Issue(21) :3167-3170.DOI:10.13699/j.cnki.1001-6821.2024.21.020

中医药调控p38-MAPK信号通路在心力衰竭心肌纤维化中的研究现状

Research status on the regulation of the p38-MAPK signaling pathway in myocardial fibrosis of heart failure using traditional Chinese medicine

王一博 1沙万敏 1秦亚录 2魏华 3毛琪玥 1王言1
扫码查看

作者信息

  • 1. 成都中医药大学临床医学院,四川成都 610075
  • 2. 成都中医药大学附属第三医院/成都市郫都区中医医院心内科,四川成都 611730
  • 3. 成都中医药大学附属第三医院/成都市郫都区中医医院肺病科,四川成都 611730
  • 折叠

摘要

在心力衰竭(HF)发展进程中,p38-丝裂原激活蛋白激酶(MAPK)的过度表达被认为是导致心肌纤维化(MF)的关键通路.中药活性成分、中药复方及中成药通过调控p38-MAPK在防治胶原蛋白积累、抑制心肌纤维化进程、改善心力衰竭程度、提升心功能等方面都具有显著优势.本文通过总结近年来中医药在p38-MAPK信号通路治疗HF MF方面的相关研究成果,旨在为HF MF的预防和治疗上提供新的潜在作用靶点.

Abstract

The over expression of p38-mitogen-activated protein kinase(MAPK)is considered a crucial pathway leading to myocardial fibrosis(MF)in the development of heart failure(HF).Traditional Chinese medicine active ingredients,compounds,and patent medicines have significant advantages in preventing and treating collagen accumulation,inhibiting the process of myocardial fibrosis,improving the degree of heart failure,and enhancing cardiac function by regulating p38-MAPK.This article summarizes recent research on traditional Chinese medicine's treatment of HF MF through the p38-MAPK signaling pathway with the aim to provide new potential targets for preventing and treating HF MF.

关键词

中医药/p38-丝裂原激活蛋白激酶信号通路/心力衰竭/心肌纤维化

Key words

traditional Chinese medicine/p38-mitogen-activated protein kinase signal pathway/heart failure/myocardial fibrosis

引用本文复制引用

出版年

2024
中国临床药理学杂志
中国药学会

中国临床药理学杂志

CSTPCDCSCD北大核心
影响因子:1.91
ISSN:1001-6821
段落导航相关论文